Fundraising Fox
Innorna
1 known investors
Find your way into Innorna
Sign up to see every warm intro you have to Innorna
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Innorna team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BApr 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Innorna do?
- Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.
- Who are Innorna's investors?
- Innorna's investors include Blue Ocean Capital Group.